Clinical Trial Update: Low-Dose Weekly vs High-Dose Cisplatin [NA]

View source ↗

Summary

A clinical trial comparing low-dose weekly versus high-dose cisplatin in locally advanced head and neck squamous cell carcinoma is currently in recruiting statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | NA | Status: RECRUITING